Treatment effect quantification for time‐to‐event endpoints–Estimands, analysis strategies, and beyond
Author:
Affiliation:
1. Methods, Collaboration, and Outreach Group (MCO), Department of BiostatisticsHoffmann‐La Roche Ltd Basel Switzerland
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.1917
Reference77 articles.
1. Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
2. A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease
3. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
4. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
5. Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints’ definitions in cancer clinical trials
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. External comparators and estimands;Frontiers in Drug Safety and Regulation;2024-02-02
2. Duration of and time to response in oncology clinical trials from the perspective of the estimand framework;Pharmaceutical Statistics;2023-10-02
3. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching;Clinical Trials;2023-07-16
4. Two‐sample inference procedures under nonproportional hazards;Pharmaceutical Statistics;2023-07-10
5. Application of estimand framework in ICH E9 (R1) to vaccine trials;Journal of Biopharmaceutical Statistics;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3